Literature DB >> 25892192

Although not consistently superior, the absolute approach to framing the minimally important difference has advantages over the relative approach.

Yuqing Zhang1, Shiyuan Zhang1, Lehana Thabane1, Toshi A Furukawa2, Bradley C Johnston3, Gordon H Guyatt4.   

Abstract

OBJECTIVES: Using studies that established minimal important difference (MID) using anchor-based methods, we set out to address the relative merits of absolute and relative changes in establishing an instrument's MID. STUDY DESIGN AND
SETTING: In seven data sets, we calculated correlations between global change ratings and absolute and relative score changes and conducted meta-analyses. We considered that the measure with the higher correlation represented the more valid approach.
RESULTS: The meta-analyses showed no significant difference between pooled correlations of absolute and relative difference on health-related quality of life instrument with global transition scores of symptoms, emotional function, physical function, and cognitive function. In four of five domains, there was at least one study in which the absolute was significantly superior to the relative; in one of these four, one study showed statistically significant superior performance of the relative. In an analysis restricted to patients with low baseline scores for the domain of cognitive function, the relative approach showed higher correlation with global rating than did the absolute approach.
CONCLUSION: Although we found no consistent superiority of either approach to establishing the MID, when differences existed they usually favored the absolute, which also has advantages of simplicity and ease of pooling across studies. Researchers may consider the absolute as a default but also compare both methods on an instrument by instrument basis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anchor-based method; Global rating of change; HRQOL; Health-related quality of life; MCID; MID; Minimal important different; PRO; Patient-reported outcomes

Mesh:

Year:  2015        PMID: 25892192     DOI: 10.1016/j.jclinepi.2015.02.017

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Minimal Important Difference in Voice Handicap Index-10.

Authors:  Stephanie Misono; Bevan Yueh; Ali N Stockness; Meaghan E House; Schelomo Marmor
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-11-01       Impact factor: 6.223

2.  Quality of Life in Palliative Care.

Authors:  Mellar P Davis; David Hui
Journal:  Expert Rev Qual Life Cancer Care       Date:  2017-11-08

Review 3.  Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations.

Authors:  Tahira Devji; Gordon H Guyatt; Lyubov Lytvyn; Romina Brignardello-Petersen; Farid Foroutan; Behnam Sadeghirad; Rachelle Buchbinder; Rudolf W Poolman; Ian A Harris; Alonso Carrasco-Labra; Reed A C Siemieniuk; Per O Vandvik
Journal:  BMJ Open       Date:  2017-05-11       Impact factor: 2.692

4.  Power estimations for non-primary outcomes in randomised clinical trials.

Authors:  Janus Christian Jakobsen; Christian Ovesen; Per Winkel; Jørgen Hilden; Christian Gluud; Jørn Wetterslev
Journal:  BMJ Open       Date:  2019-06-06       Impact factor: 2.692

5.  Minimal important difference and patient acceptable symptom state for the Numerical Rating Scale (NRS) for pain and the Patient-Rated Wrist/Hand Evaluation (PRWHE) for patients with osteoarthritis at the base of thumb.

Authors:  Susanna Stjernberg-Salmela; Teemu Karjalainen; Joona Juurakko; Pirjo Toivonen; Eero Waris; Simo Taimela; Clare L Ardern; Teppo L N Järvinen; Jarkko Jokihaara
Journal:  BMC Med Res Methodol       Date:  2022-04-29       Impact factor: 4.612

Review 6.  Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis.

Authors:  Nathan Evaniew; Emilie P Belley-Côté; Nader Fallah; Vanessa K Noonan; Carly S Rivers; Marcel F Dvorak
Journal:  J Neurotrauma       Date:  2015-12-15       Impact factor: 5.269

7.  A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal.

Authors:  Joanne C Rothwell; Steven A Julious; Cindy L Cooper
Journal:  Trials       Date:  2018-10-10       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.